Braskem S.A. (BAK) Price Target Analysis
Updated Jun 26, 2026
Analyst Rating: Buy
Based on 6 analysts39.5% Above Target
BAK trades 39.5% above Wall Street's consensus target of $1.50.
Current Price$2.48
Average Target$1.50
Low$1.50
Median$1.50
High$1.50
Analyst Target Range
Forward P/E0.9x
(Value)
PEG Ratio—
Implied Growth+112.2%
(High Growth)
Analyst Spread0.0%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes BAK achieves its forward estimates and maintains a stable P/E multiple of 0.9x. This scenario reflects the blended consensus of 6 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
BAK Price Target Analysis
Updated June 28, 2026As of June 28, 2026, Braskem S.A. (BAK) has a Wall Street consensus price target of $1.50, based on estimates from 6 covering analysts. With the stock currently trading at $2.48, this represents a potential downside of -39.5%. The company has a market capitalization of $988M.
Analyst price targets range from a low of $1.50 to a high of $1.50, representing a 0% spread in expectations. The median target of $1.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, BAK trades at a trailing P/E of -0.5x and forward P/E of 0.9x. Analysts expect EPS to grow +112.2% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Basic Materials stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+28.4%
Industry Consensus
Avg Forward P/E
42.9x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 LYBLyondellBasell Industries N.V. | $18.0B | $55.73 | $80.20 | +43.9% | Hold | 5.9x | 39 |
 WLKWestlake Corporation | $9.8B | $76.62 | $116.33 | +51.8% | Hold | 20.2x | 32 |
 OLNOlin Corporation | $2.5B | $21.73 | $28.30 | +30.2% | Hold | 247.2x | 35 |
 TROXTronox Holdings plc | $1.1B | $6.69 | $8.33 | +24.5% | Buy | — | 17 |
 AVNTAvient Corporation | $3.5B | $37.91 | $46.71 | +23.2% | Buy | 12.3x | 20 |
 DOWDow Inc. | $20.9B | $29.04 | $39.36 | +35.5% | Hold | 9.1x | 35 |
 LINLinde plc | $240.8B | $519.62 | $562.14 | +8.2% | Buy | 29.0x | 28 |
 EMNEastman Chemical Company | $8.1B | $70.71 | $79.89 | +13.0% | Buy | 11.1x | 35 |
 CECelanese Corporation | $5.5B | $49.42 | $65.60 | +32.7% | Hold | 8.0x | 37 |
 HUNHuntsman Corporation | $2.0B | $11.41 | $13.80 | +20.9% | Hold | — | 33 |
BAK — Frequently Asked Questions
Quick answers to the most common questions about buying BAK stock.
What is the BAK stock price target for 2026?
BAK's consensus price target is $1.5, -39.5% below the current price of $2.48. The 6 analysts tracking BAK see downside risk at present valuations.
Is BAK a buy, sell, or hold?
BAK has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $1.5 implies -39.5% downside from current levels.
Is BAK stock overvalued or undervalued?
With a forward P/E of 0.8909x, BAK trades at a relatively low valuation. The consensus target of $1.5 implies -39.5% move, suggesting the market may be pricing in risks.
How high can BAK stock go?
The most bullish Wall Street analyst has a price target of $1.5 for BAK, while the most conservative target is $1.5. The consensus of $1.5 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover BAK stock?
BAK is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the BAK stock forecast?
The 12-month BAK stock forecast based on 6 Wall Street analysts shows a consensus price target of $1.5, with estimates ranging from $1.5 (bear case) to $1.5 (bull case). The median consensus rating is "Buy".
What is BAK's forward P/E ratio?
BAK trades at a forward P/E ratio of 0.9x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy BAK stock?
Analysts are cautious on BAK, with 0 Sell ratings and a price target of $1.5 (-39.5% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do BAK price targets vary so much?
BAK analyst price targets range from $1.5 to $1.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $1.5 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare